A Recap of the McDermott Will & Emery Life Sciences Deal-making Symposium

I was pleasantly surprised by how much l learned at the McDermott Will & Emery Life Sciences Deal-making symposium last week.  I don’t say that by inferring I know a lot, in quite the opposite, but what I mean is that a lot of conferences and events are the same content but with different names … Continue reading A Recap of the McDermott Will & Emery Life Sciences Deal-making Symposium

Articles of the Week

Here is a collection of articles I have found both relevant and timely in respects to the life science and healthcare industry over the past week or so. There are 503 pages in the new tax law – 12 of those pages could dramatically impact the Private Equity sector (The American Prospect) Investment in Digital … Continue reading Articles of the Week

Hello, let me tell you about what this blog is all about!

Welcome and thank you for visiting MattCorc.com.  The goal of this blog is to provide background on issues that could cripple a company’s balance sheet but that are potentially avoidable through the use of risk transfer mechanisms. The focus will be on companies that operate in the Life Science space, a rather broad definition of … Continue reading Hello, let me tell you about what this blog is all about!